Common and uncommon adverse reactions were determined from pooled safety data from a clinical trial population of 1573 treated patients encompassing 12 clinical studies. Very rare adverse reactions were primarily determined from post-marketing experience data and therefore refer to reporting rate rather than true frequency. (See table.)
 Click on icon to see table/diagram/image
Click on icon to see table/diagram/image
                    View ADR Reporting Link
                
                                 
 
            
 
         
                 
                                     
                             
                                             
                                             Sign Out
 Sign Out
                                     
                                             
                                             
                                            